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Iron metabolism is regulated by transcriptional and
post-transcriptional mechanisms. The mRNA of the
iron-controlling gene, transferrin receptor 1 (TfR1),
has long been believed to be negatively regulated by
a yet-unidentified endonuclease. Here, we show that
the endonuclease Regnase-1 is critical for the degra-
dation of mRNAs involved in iron metabolism in vivo.
First, we demonstrate that Regnase-1 promotes
TfR1mRNA decay. Next, we show thatRegnase-1/
mice suffer from severe iron deficiency anemia,
although hepcidin expression is downregulated. The
iron deficiency anemia is induced by a defect in
duodenal iron uptake. We reveal that duodenal
Regnase-1 controls the expression of PHD3, which
impairs duodenal iron uptake via HIF2a suppression.
Finally, we show that Regnase-1 is a HIF2a-inducible
gene and thus provides a positive feedback loop for
HIF2a activation via PHD3. Collectively, these results
demonstrate that Regnase-1-mediated regulation of
iron-related transcripts is essential for the mainte-
nance of iron homeostasis.
INTRODUCTION
Iron metabolism is one of the most tightly controlled systems in
mammals. Iron is required for essential biological functions,
including oxygen delivery, but iron overload has deleterious ef-
fects, as seen in hemochromatosis. In order to circumvent iron
deficiency and/or overload, iron uptake and storage is coordi-
nately regulated by sensing systemic iron levels. Moreover,
iron metabolism is closely linked to infection and inflammation,
as well as systemic iron levels (Ganz and Nemeth, 2015; Muck-
enthaler et al., 2017).
Iron metabolism is regulated by both transcriptional and
post-transcriptional mechanisms. Upon iron overload or inflam-
mation, an iron hormone, hepcidin (encoded by Hamp), is tran-
scribed in hepatocytes. Released hepcidin promotes the inter-
nalization and degradation of the sole known iron exporter in
mammals, ferroportin (Fpn1, Slc40a1), leading to iron retention
in the spleen and liver and to blockade of iron absorption in the
duodenum (Drakesmith et al., 2015). Recently, it has also been
revealed that hepcidin expression is controlled by an erythroid
regulator, erythroferrone, produced by erythroblasts in response
to erythropoietin (Kautz et al., 2014). Another essential regulator
of iron homeostasis, especially for iron uptake in the duodenum,
is the transcription factor hypoxia-inducible factor-2a (HIF2a).
The HIF2a protein is stabilized by the inactivation of prolyl-hy-
droxylase-domain-containing proteins (PHD1-3, encoded by
Egln1-3) and factor inhibiting HIF-1 (FIH), which are sensors for
hypoxia and iron deficiency (Shah and Xie, 2014). Among these
HIF hydroxylases, it has been suggested that PHD3 is relatively
more effective in the degradation of HIF2a (Appelhoff et al.,
2004). HIF2a forms a heterodimeric complex with aryl hydrocar-
bon receptor nuclear translocator (ARNT and HIF1b) and binds
to the hypoxia-response element (HRE; typically 50-RCGTG-30,
where R = A/G). HIF2a activates the transcription of iron-control-
ling genes that harbor HREs, including duodenal cytochrome B
(Dcytb andCybrd1), divalent metal transporter 1 (Dmt1,Nramp2,
and Slc11a2), ferroportin (Fpn1), and presumably transferrin re-
ceptor 1 (TfR1 and Tfrc), thereby promoting efficient duodenal
iron uptake under iron-deficient conditions (Mastrogiannaki
et al., 2009; Shah et al., 2009; Taylor et al., 2011).
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At the post-transcriptional level, mRNAs of the genes relating
to iron transport and storage are widely regulated through the
iron response element (IRE) iron response protein (IRP) axis
(K€uhn, 2015; Muckenthaler et al., 2017; Wilkinson and Panto-
poulos, 2014). In their iron-deficient state, IRPs modulate the
translation and stability of mRNAs through binding to IREs in
the 50 and 30 UTR, respectively. In addition to regulation by
IRPs, it has long been thought that TfR1 mRNA is controlled by
endogenous ribonucleases (Binder et al., 1994; Muckenthaler
et al., 2017). However, the endonucleases responsible for the
TfR1 mRNA decay have not yet been identified.
We previously identified Regnase-1 (Reg1; also known as
MCPIP1 or Zc3h12a) as an endonuclease that can destabilize a
set ofmRNAs, including interleukin-6 (Il-6) and Il-12p40 (Matsush-
ita et al., 2009; Mino et al., 2015). Reg1 is a cytoplasmic protein,
which contains a CCCH-type zinc-finger motif and a N-terminal
conserved domain that is similar to the PilT N terminus (PIN)
domain andserves as a nuclease enzyme (Arcus et al., 2011;Mat-
sushita et al., 2009). Unlike another CCCH-type zinc-finger
protein, tristetraprolin (TTP), which recognizes and destabilizes
mRNAs containing AU-rich elements (ARE) (Kafasla et al., 2014),
Reg1 promotes the decay of mRNAs with stem-loop motifs in a
translation-dependent manner (Mino et al., 2015). Genome-wide
analysis has revealed that the canonical loop pattern of Reg1
target mRNAs is pyrimidine-purine-pyrimidine (e.g., UAU or
UGU) (Mino et al., 2015). The essential role of Reg1 in immune re-
sponses has been intensively studied.Reg1/mice develop se-
vere autoimmune disease, in which Reg1/ T cells substantially
contribute to the pathology (Iwasaki et al., 2011;Matsushita et al.,
2009; Uehata et al., 2013). Reg1 is thus a pivotal post-transcrip-
tional regulator in immune responses. Interestingly, we also found
thatmice deficient in Reg1 suffer from severe anemia (Matsushita
et al., 2009). However, the mechanisms by which mice with Reg1
deficiency develop anemia have remained obscure.
In the current study, we investigated the role of Reg1 in iron
metabolism. We found augmented expression of TfR1 in Reg1-
deficient cells, resulting from a lack of direct destabilization of
TfR1mRNA by Reg1. Analysis of knockout mice further revealed
that the ribonuclease activity of Reg1 destabilized the mRNA of
another iron-controlling gene,PHD3, contributing to efficient iron
uptake in the duodenum. Moreover, the expression of Reg1 in
the duodenumwas controlled under conditions of iron deficiency
through the activity of HIF2a. Thus, Reg1 forms a critical positive
feedback loop for HIF2a activation to promote duodenal iron
uptake.
RESULTS
TfR1 Expression Is Elevated in the Absence of Reg1
To explore Reg1 target genes associated with the regulation of
iron homeostasis, we first analyzed the previous microarray da-
taset of Reg1/ macrophages cultured in standard medium
(Matsushita et al., 2009). We found that TfR1 was upregulated
under deficiency of Reg1 (Table S1). Since the expression of
TfR1 is highly affected by intracellular iron levels, we depleted
iron in the culture medium by adding an iron chelator, deferox-
amine mesylate (DFO). In this iron-depleted medium, TfR1
mRNA expression was significantly higher in Reg1/ peritoneal
exudate cells (PECs) than in those from wild-type mice
(Figure 1A).
Also, to confirm that this upregulation of TfR1 is ubiquitous
among various cell types, we conducted flow cytometry analysis
to assess the expression in splenocytes of Reg1/ mice. In the
absence of Reg1, significantly higher levels of TfR1 were de-
tected not only in cells relating to iron homeostasis, including
Ter119+ erythroblasts and CD11bloF4/80+ red pulp macro-
phages, but also in CD3ε+ T cells, B220+ B cells, Gr-1+Mac1+
myeloid cells, and Ly6G+CD115 neutrophils (Figure 1B),
suggesting a cell-type-independent regulation of TfR1 expres-
sion. TfR1 expression was significantly higher inReg1/ splenic
cells, even after iron treatment in vitro and in vivo (Figures S1A
and S1B). Taken together, these results indicate that TfR1
expression is negatively regulated by Reg1 in various hemato-
poietic cells.
TfR1 mRNA Is Directly Regulated by Reg1
The upregulation of TfR1 in the absence of Reg1 prompted us to
test whether Reg1 directly regulates TfR1 via its ribonuclease ac-
tivity. qRT-PCR analysis revealed that TfR1mRNAwas stabilized
in the absence of Reg1 compared to the control after treatment
with the transcription inhibitor, actinomycin D (ActD) (Figure 2A).
Reciprocally, under overexpression of Reg1, the decay rate of
TfR1 mRNA was accelerated compared to the control (Fig-
ure 2B). We next asked whether Reg1 is associated with TfR1
mRNA and performed RNA immunoprecipitation (RIP)-qPCR
analysis. We found that TfR1 mRNA, but not 18S rRNA, co-
precipitated with a Reg1-D141N nuclease-inactive mutant (Fig-
ure 2C), indicating Reg1 directly associates with TfR1 mRNA.
Next, to test whether the 30 UTR of TfR1mRNA is sufficient for
Reg1-mediated mRNA decay, we inserted the full-length 30 UTR
ofmouse TfR1mRNA (mTfR1-30 UTR-full) into luciferase reporter
constructs (pGL3) and assessed the luciferase activity under
overexpression of Reg1 (Figure 2D). We found that Reg1 overex-
pression reduced the luciferase activity of pGL3-mTfR1-30 UTR-
full compared to control (Figure 2E). Then, to further investigate
the regions critical for conferring Reg1 responsiveness, wemade
a series of pGL3s containing a part of the 30 UTR of TfR1
mRNA (Figure 2D). The TfR1 30 UTR harbors five evolutionarily
conserved IREs, and the endonucleolytic cleavage site in
TfR1 30 UTR is believed to be located among IREs (Binder
et al., 1994). Indeed, the luciferase activity of pGL3-mTfR1-30
UTR-(768–1,525), which contains all IREs, decreased under
Figure 1. Elevation of TfR1 in the Absence of Reg1
(A) Mouse PECs from Reg1/mice were incubated in medium supplemented with 100 mMDFO. After overnight incubation, total RNA was extracted, and levels
of TfR1 mRNA were measured by qRT-PCR. Data are representative of five independent experiments.
(B) Total splenocytes from Reg1/mice were analyzed using flow cytometry as indicated (left). Data are representative of four biological replicates. Histograms
of TfR1 intensity and TfR1 mean fluorescence intensity (MFI) in each gated population (n = 4) (right).
Data are expressed asmean ±SD of triplicates (A) or biological replicates (B). *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test). See also Figure S1 and Table S1.
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overexpression of wild-type Reg1 (Figure 2E). Furthermore,
whereas the luciferase activity of pGL3-mTfR1-30 UTR-(768–
940) was not altered by co-expression of Reg1, the activity of
pGL3-mTfR1-30 UTR-(768–960) decreased (Figure 2E), suggest-
ing the sequence between 940 and 960 is critical for regulating
TfR1 mRNA decay. The sequence between 944 and 958 in the
30 UTR of mouse TfR1 mRNA is in close proximity to an IRE
and predicted to form a stem-loop structure with a pyrimidine-
purine-pyrimidine loop (Figure 2G), which is consistent with the
consensus Reg1 recognition motif (Mino et al., 2015). The addi-
tion of this sequence to the end of b-globin 30 UTR reduced lucif-
erase activity in the presence of wild-type Reg1, but not the
D141Nmutant, indicating that Reg1 acts as a nuclease to desta-
bilize TfR1 30 UTR (Figure 2F). The minimal sequence between
944 and 958 in mouse TfR1 mRNA is identical to that of human
and evolutionarily conserved among a variety of mammals (Fig-
ure 2H), suggesting a functional significance for the regulation of
TfR1 mRNA.
Next, we further investigated the relationship between Reg1
and IRPs by co-transfecting cells with a luciferase reporter con-
taining full-length TfR1 30 UTR and the expression vectors of
Reg1 and IRPs. Luciferase activity was reduced when the dose
of the Reg1 expression vector was increased (Figure 2I), indi-
cating that Reg1 has the potential to counteract mRNA stabiliza-
tion by IRP1 and IRP2. These results collectively support the
view that Reg1 is an endonuclease destabilizing TfR1 mRNA
via its 30 UTR.
Reg1/ Mice Show Severe Iron Deficiency Anemia
To further investigate the role of Reg1 in iron homeostasis, we
next assessed the effect of the genetic ablation of Reg1 in
mice. In our previous study, we showed that Reg1/ mice suf-
fered from severe anemia (Matsushita et al., 2009). This finding
was corroborated by the observation that hematological param-
eters of Reg1/ mice, including red blood cell (RBC) numbers,
hemoglobin (HGB), and hematocrit (HCT) levels, progressively
deteriorated with maturation (Figure 3A). Also, non-heme iron
levels were markedly lower in serum and iron-storage tissues,
including the liver and spleen, in Reg1/ mice (Figures 3B and
3C). Tissue iron staining also confirmed low accumulation of
iron in the spleen and liver inReg1/mice (Figure 3D), indicating
Reg1/ mice also suffered from severe iron deficiency. More-
over, the mRNA levels of hepcidin were almost undetectable
in the liver of Reg1/ mice (Figure 3E), although these mice
developed spontaneous severe autoimmune disease and
inflammation. We also found that the unbound iron-binding
capacity (UIBC) and total iron-binding capacity (TIBC) signifi-
cantly increased in Reg1/ mice, while transferrin saturation
decreased in Reg1/ mice (Figure 3F), supporting the notion
that this anemia is iron deficiency anemia rather than anemia
of inflammation. Moreover, we found that the expression of
erythropoietin was augmented in Reg1/ kidney (Figure 3G),
consistent with decreased HGB levels. Furthermore, we exam-
ined erythroferrone expression in bone marrow cells and
spleen from Reg1/ mice and found that expression was
upregulated in these organs (Figure 3H), which might be
one possible explanation for hepcidin downregulation. Taken
together, these findings indicate that Reg1/ mice spontane-
ously develop iron deficiency anemia, while hepcidin expression
is downregulated.
Next, we analyzed gene expression in the liver of Reg1/
mice to examine if Reg1 expressed in the liver controls iron up-
take, thereby inducing iron deficiency anemia. We found that
mRNA levels of the genes responsible for iron uptake in the liver,
including TfR1 and Dmt1, were significantly upregulated
in Reg1/ liver (Figure S2A), consistent with their regulation
by the IRE-IRP system. Therefore, we next analyzed the IRP
expression in the liver and found that IRP2 protein accumulated
in Reg1/ liver (Figure S2B). IRP2 protein accumulation was
also observed in Reg1/ heart (Figure S2B), suggesting that
this upregulation was observed in multiple organs in Reg1/
mice. Consistent with the accumulation of IRP2 protein, we
found that ferritin expression was downregulated in Reg1/
liver at the protein level (Figure S2D). The upregulation of
IRP2 protein is not due to post-transcriptional regulation of
IRP mRNA by Reg1, because the expression of IRP1 or IRP2
mRNA was not augmented in Reg1-deficient tissues (Fig-
ure S2F). These findings suggest that the IRP activation is
induced by cytosolic iron depletion in the liver under Reg1 defi-
ciency, which is consistent with the severe iron deficiency found
in Reg1/ mice. Therefore, it is unlikely that the aberrant regu-
lation of the IRE-IRP system in the liver is the primary cause of
iron deficiency anemia in Reg1/ mice.
It is known that autoimmune disease can induce anemia
via several mechanisms (Weiss and Goodnough, 2005;
Zhou et al., 2013). Given that Reg1/ mice develop severe
Figure 2. TfR1 mRNA Is Directly Regulated by Reg1
(A) PECs harvested from Reg1/ mice were incubated overnight in the medium supplemented with DFO (100 mM). The cells were then treated with ActD
(1 mg/mL) and hemin (100 mM) for the indicated times. Total RNA was extracted, and the levels of TfR1 mRNA were measured by qRT-PCR.
(B) HEK293 Tet-Off cells were co-transfected with pTREtight-mTfR1-CDS-30 UTR, together with the Reg1 expression vector or the control (mock). Total RNAwas
extracted after doxycycline hyclate (Dox; 1 mg/mL) treatment, and the levels of TfR1 mRNA were measured by qRT-PCR.
(C) HEK293T cells were transfected with mutant Reg1 (Reg1-D141N) expression vector or the control (empty). RNA-protein complexes were immunoprecipi-
tated, and the levels of TfR1 mRNA and 18S rRNA were measured by qRT-PCR.
(D–F) HEK293T cells were co-transfected with a series of luciferase reporter plasmids (D) and the expression plasmids for wild-type Reg1 (Reg1-WT), Reg1-
D141N, or empty plasmid as a control (mock). After 48 hr of incubation, luciferase activity of cell lysates was determined (E and F).
(G) The predicted stem-loop structure of mouse TfR1 30 UTR-(944–958).
(H) Alignment of the conserved sequence in TfR1 30 UTR among mammals.
(I) HEK293T cells were co-transfected with either IRP1 or IRP2 expression vector, together with pGL3-hTfR1-30 UTR-full, and the Reg1 expression plasmid or the
control.
Data are representative of two (C) or three (A, B, E, F, and I) independent experiments. Data are expressed as mean ± SD of triplicates (A–C and E) or duplicates
(F and I). *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test).
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autoimmune disease due to T cell activation (Matsushita et al.,
2009; Uehata et al., 2013), aberrant activation of the adaptive im-
mune system might induce such anemia in Reg1/ mice. To
exclude this possibility, we generated mice deficient in Rag2
and Reg1 (Rag2/Reg1/mice), in which mature lymphocytes
as well as immunoglobulins are absent. Indeed, white blood cell
numbers were significantly lower in Rag2/Reg1/ mice than
in Reg1/ mice (Figure S3A). On the other hand, hematological
parameters (including RBC, HGB, and HCT levels; and mean
corpuscular HGB concentration [MCHC]) and tissue iron levels
were significantly lower in Rag2/Reg1/ mice than in control
mice but comparable to those of Reg1/mice (Figures S3A and
S3B). These findings indicate that lymphocyte deficiency does
not ameliorate iron deficiency anemia in Reg1/ mice. Auto-
immune gastritis is also known to be a cause of anemia, since
the stomach lining is crucial for the facilitation of vitamin B12
and iron absorption. However, histopathological analysis of
gastrointestinal tracts, including the stomach from Reg1/
and Rag2/Reg1/mice, revealed little evidence of inflamma-
tion, such as lymphocyte infiltration (Figure S3C), indicating that
the anemia was not caused by gastritis. We also performed such
histopathological analyses on other organs and found infiltration
of inflammatory cells in Reg1/ and Rag2/Reg1/ liver,
although this change did not lead to the upregulation of hepcidin
mRNA in Rag2/Reg1/ liver (Figures S3C and S3D). Collec-
tively, these results suggest that Reg1 directly controls iron
homeostasis independent of inflammation.
Reg1 Is Required for Duodenal Iron Uptake
Next, we further investigated the mechanisms of iron deficiency
anemia in Reg1/mice. Since there is no excretory pathway for
iron under physiological conditions, pathologic iron loss and/or
impaired iron absorption can be the cause of iron deficiency.
As for iron loss, no obvious bleeding, including gastrointestinal
hemorrhage, was observed (data not shown). Therefore, we
next focused on the duodenum, which is a region critical for
the uptake of iron in the diet. Tissue iron levels were significantly
lower in Reg1/ duodenum (Figure 4A). Histological analysis of
iron staining confirmed remarkable tissue-iron reduction in the
duodenal epithelium of Reg1/ mice and Rag2/Reg1/
mice (Figures 4B and S3C). These findings indicate that the du-
odenum could not access dietary iron efficiently in Reg1/
mice.
To investigate the role of Reg1 in the duodenum, we next
generated mice lacking Reg1 specifically in the intestinal epithe-
lium (Reg1fl/flVillin-Cre+ mice). The levels of Reg1 mRNA in the
duodenal epithelial cells of Reg1fl/flVillin-Cre+ mice decreased
substantially (Figure 4C). First, we asked whether these mice
show any evidence of inflammation. Histological, qRT-PCR,
and flow cytometric analyses revealed no spontaneous immune
activation in Reg1fl/flVillin-Cre+ mice, including colitis (Figures
S4A–S4E). The absence of spontaneous immune activation in
Reg1fl/flVillin-Cre+ mice makes them suitable for the study of
iron metabolism.
Next, we asked whether intestinal Reg1 plays a role in iron ho-
meostasis. Reg1fl/flVillin-Cre+ mice showed lower HGB and HCT
levels and lower mean corpuscular volume (MCV) and MCHC at
the age of 4–6 weeks (Figure 4D). Tissue iron levels in the liver
and spleen were also significantly lower in 4- to 6-week-old
Reg1fl/flVillin-Cre+ mice than in control mice (Figure 4E). Further-
more, consistent with the low tissue iron levels, hepcidin expres-
sion levels in the liver were significantly lower in Reg1fl/flVillin-
Cre+ mice than in control mice (Figure 4F). Taken together, these
findings demonstrate that Reg1 expressed in intestinal epithe-
lium cells regulates iron homeostasis and erythropoiesis in vivo.
These observations led us to hypothesize that impaired
duodenal iron absorption is the cause of iron deficiency anemia
in Reg1/ mice. To test this hypothesis, we analyzed mice that
were intraperitoneally injectedwith saccharated ferric oxide (Fig-
ure S5A). As expected, iron administration into mice deficient in
Reg1 partially restored tissue iron levels and HGB levels (Figures
4G, 4H, and S5B). Also, hepcidin expression in Reg1/ liver
became comparable to that of untreated wild-type mice, pre-
sumably in response to the restoration of iron levels (Figure S5C),
suggesting that the regulation of hepcidin expression is intact in
Reg1/ mice. In the aggregate, these findings suggest that
impaired duodenal iron absorption contributed to altered iron
homeostasis in Reg1/ mice.
Reg1 Deficiency in the Duodenum Does Not Induce
Ferritin Expression
It is well known that upregulation of ferritin H due to IRP inactiva-
tion in the duodenum leads to iron deficiency (Galy et al., 2013;
K€uhn, 2015; Vanoaica et al., 2010). However, we did not observe
the upregulation of ferritin H or IRP inactivation in Reg1/ duo-
denum (Figures S2C and S2E). Therefore, these findings rule out
Figure 3. Reg1/ Mice Develop Severe Iron Deficiency Anemia
(A) Hematological parameters of Reg1/ mice at indicated time points (n = 4–10).
(B) Iron levels of each organ from Reg1/ mice (n = 4).
(C) Serum iron levels of Reg1/ mice (n = 9).
(D) Berlin blue stain of the liver (top) and the spleen (bottom) from Reg1/ mice to detect tissue iron. Representative images of each genotype are shown.
(E) Hepcidin mRNA expression levels in the liver of control,Reg1/ and iron-deficient (ID) mice (n = 4–5). Control and Reg1/mice were fed with regular diet. As
iron-deficient mice, age-matched wild-type mice were fed with an iron-deficient diet for 4 weeks.
(F) UIBC, TIBC, and transferrin saturation in Reg1/ mice (n = 3–4).
(G) Erythropoietin mRNA expression levels in Reg1/ kidney (n = 8).
(H) Erythroferrone mRNA expression levels in the bone marrow cells and spleen of Reg1/ mice (n = 6–7).
Each symbol represents the value from individual mice. Horizontal lines indicate the mean (B, C, and F). Data are expressed as mean ± SD (A, E, G, and H). Data
were pooled from 13 (A), 3 (C and G), 2 (F), or 4 (H) independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test compared to Reg1/mice at
3 weeks of age (A) or control (B, C, and F–H) or by one-way-ANOVAwith Bonferroni correction (E). #p < 0.05, ##p < 0.01, ###p < 0.001 (Student’s t test) compared
to control (A).
See also Figures S2 and S3.








Figure 4. Reg1 Is Required for Duodenal Iron Uptake
(A) Iron levels of the duodenums from Reg1/ mice (n = 6).
(B) Berlin blue stain of the duodenum. Representative images of each genotype are shown.
(C) Reg1 mRNA expression levels in the duodenal epithelial cells and liver of Reg1fl/flVillin-Cre+ mice (n = 5).
(D) Hematological parameters of Reg1fl/flVillin-Cre+ mice at the age of 4–6 weeks. (n = 9). WBC, white blood cell.
(legend continued on next page)
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the possibility that the pathogenicmechanisms of iron deficiency
anemia in Reg1/mice are associated with ferritin upregulation
in the duodenum.
Reg1 Controls Duodenal Iron Uptake via the PHD3-
HIF2a Axis
To identify Reg1 target genes regulating iron uptake, we con-
ducted transcriptome analysis in wild-type and Reg1/ duo-
denum and compared mRNA expression levels (Figure 5A).
Gene ontology (GO) analysis revealed that a large number of up-
regulated genes in Reg1/ duodenum were related to immune
regulation or response (Table S2; Figures S6A and S6C). To
focus on the iron-related targets of Reg1, we excluded genes
whose GO was associated with immune regulation or response
or those without a GO annotation, and we explored candidate
genes regulating iron homeostasis (Figure S6B). Of non-immune
related genes, top-ranked upregulated genes in Reg1/ duo-
denum were sorted by multiple-testing-adjusted p value (Fig-
ure 5B; Table S2; Supplemental Experimental Procedures).
Among the top-ranked genes shown in Figure 5B, Egln3 was
one of the most highly expressed genes in Reg1/ duodenum
(p = 6.15 3 108). In addition to Egln3, we found another poten-
tial target of duodenal Reg1, Hif3a, as an iron-related gene,
although these genes are not depicted in Figure 5B (p = 5.08 3
103). The augmented expression of these genes was validated
by qRT-PCR analysis (Figures 5C and S6D). Since the p value of
Egln3 in the Reg1/ duodenum is substantially lower than that
of Hif3a, we next set out to analyze the role of Egln3 (PHD3).
To date, four prolyl hydroxylases (PHD1–4, Egln1-4) for HIF
have been identified, and PHD1–3 are thought to be crucial for
inhibiting HIF activity (Kaelin and Ratcliffe, 2008). qRT-PCR anal-
ysis revealed that PHD3 is the most highly upregulated gene
among these three PHD family members (Figure 5C). We next
examined the relative expression of each PHD family member
by comparing RPKM (reads per kilobase per million mapped
reads) of the transcriptome data of PHD family members, since
redundancy has been reported in controlling HIF activity (Tanigu-
chi et al., 2014). Whereas PHD1 (Egln2) and PHD3mRNAs were
expressed in wild-type duodenum, PHD3 mRNA was highly
elevated and dominantly expressed under Reg1 deficiency
(Figure 5D). In contrast, expression of PHD1 mRNA was most
abundant in both wild-type and Reg1/ liver (Figure 5D). This
difference in the relative contribution of each family member
may account for the tissue-specific regulation of HIF activity by
Reg1. Moreover, PHD3 expression was highly augmented in
Reg1/ duodenum compared to control at the protein level
(Figure 5E).
To investigate whether PHD3 mRNA is destabilized by Reg1,
we next inserted the full-length 30 UTR of mouse PHD3 mRNA
into a pGL3 construct and assessed luciferase activity under
conditions of Reg1 overexpression. Indeed, the addition of full-
length 30 UTR of PHD3 mRNA reduced the luciferase activity in
the presence of wild-type Reg1, but not Reg1-D141N (Figure 5F).
By expressing reporter constructs harboring four distinct regions
of PHD3 30 UTR, we found that mPHD3-30 UTR-(801–1,230)
is responsive to wild-type Reg1, while (1–430), (401–830), and
(1,201–1,643) are not (Figure S6E). A putative stem-loop
structure with a pyrimidine-purine-pyrimidine loop sequence
(912–935) (Figure S6F) was discovered in the PHD3 30 UTR
(801–1,230) sequence, whose addition in the reporter gene
conferred Reg1 responsiveness (Figure S6G). To further confirm
that PHD3mRNA destabilization is accelerated by Reg1, we as-
sessed themRNAdecay assay using the Tet-Off system. Indeed,
the decay rate of PHD3 mRNA was accelerated under the over-
expression of Reg1 (Figure 5G). To test whether Reg1 is associ-
ated with PHD3 mRNA, we next performed RIP-qPCR analysis.
We found that PHD3 mRNA, but not 18S rRNA, co-precipitated
with Reg1-D141N (Figure 5H), indicating that Reg1 directly rec-
ognizes PHD3 mRNA. These findings demonstrate that PHD3
mRNA is a ribonucleaolytic target of Reg1.
HIF2a regulates iron homeostasis through the induction of
Dmt1, Dcytb, and Fpn1 in the duodenum upon iron deficiency
(Shah et al., 2009; Taylor et al., 2011). To test whether these tar-
gets are upregulated in Reg1/ duodenum, we compared the
duodenums from control and Reg1/ mice fed with a normal
diet and iron-deficient wild-type mice fed with a low-iron diet
(ID mice) as a positive control of HIF2a activation. To obtain
iron-deficient mice, wild-type mice were fed with a low-iron
diet for 4 weeks, which was sufficient to induce iron deficiency
anemia similar to that observed in Reg1/ mice (Figure 6A).
Compared to the duodenum of these iron-deficient mice,
mRNA expression levels of HIF2a targets, including Dmt1,
Dcytb, Fpn1, and Slc38a1, were significantly lower in Reg1/
duodenum (Figure 6B). These findings suggest that HIF2a is
not activated in Reg1/ duodenum, even though these mice
developed severe iron deficiency and anemia. Notably, mRNA
levels of TfR1, which is presumably a HIF2a-inducible gene,
were significantly higher in Reg1/ duodenum than controls
(Figure 6B), suggesting that TfR1 mRNA is also targeted by
Reg1 in the duodenum. We next examined Fpn1 expression at
the protein level and confirmed that Fpn1 expression was not
upregulated in Reg1/ duodenum (Figure 6C). In line with these
observations, we also found that ferric reductase activity, which
determines the activity of Dcytb, was impaired in Reg1/ duo-
denum compared to that of iron-deficient mice (Figure 6D).
These findings indicate that HIF2a activity is impaired in Reg1/
duodenum.
Next, to test whether the inhibition of PHD3 activity amelio-
rates iron deficiency in Reg1/ mice, we utilized a HIF hydrox-
ylase inhibitor, DMOG. Serial intraperitoneal administration of
(E) Iron levels of each organ and serum from Reg1fl/flVillin-Cre+ mice at the age of 4–6 weeks (n = 11).
(F) Hepcidin mRNA expression levels in the liver of Reg1 fl/flVillin-Cre+ mice (n = 11).
(G) Liver iron levels of Reg1/ mice treated with saline or iron (n = 3–5).
(H) Relative change in HGB levels of Reg1/ mice before and after the serial iron administration (n = 5).
Each symbol represents the value from individual mice. Horizontal lines indicate themean (A, D, E, G, and H). Data are expressed asmean ±SD (C, F, and H). Data
were pooled from three (A, D, and F) or four (E) independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test (A, C–F, and H) or one-way ANOVA
with Bonferroni correction (G). ns, not significant. See also Figures S4 and S5.







Figure 5. Identification of the Reg1 Target Responsible for Iron Deficiency
(A) Scatterplot comparing transcriptome of the duodenum from wild-type and Reg1/ mice (n = 2). See also Table S2.
(B) Top-ranked GO-annotated genes unrelated to immune regulation or response.
(C) PHD1-3 mRNA expression levels in Reg1/ duodenum (n = 4–5).
(legend continued on next page)
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DMOG increased mRNA levels of HIF2a-inducible genes in
Reg1/ duodenum, suggesting that this treatment, at least to
some extent, reversed the HIF2a activity in Reg1/ duodenum
(Figure S5D). After treatment with DMOG, tissue iron levels in
the liver increased in Reg1/ mice, while this treatment did
not alter tissue iron levels in age-matched wild-type mice (Fig-
ures 6E and S5E). Furthermore, we asked whether genetic abla-
tion of PHD3 ameliorated anemia and iron deficiency in Reg1/
mice by utilizing mice deficient in both Reg1 and PHD3
(PHD3/Reg1/ mice). We found that HGB levels, MCV, and
splenic tissue iron levels were significantly elevated in
PHD3/Reg1/ mice compared to Reg1/ mice (Figures 6F
and 6G). Collectively, these findings suggest that Reg1 destabi-
lizes PHD3 mRNA to facilitate duodenal iron uptake.
Reg1 Is Transcriptionally Upregulated by IronDeficiency
via an HRE in Its Promoter
Next, we asked whether Reg1 expression itself is regulated by
iron concentrations. To address this question, we assessed
mRNA levels of Reg1 in the duodenum of iron-deficient mice.
Interestingly, Reg1 mRNA expression in the duodenum was
significantly higher in iron-deficient mice than in control mice
(Figure 7A). This finding suggests Reg1 expression in the duo-
denum is regulated in an iron-mediated manner.
Mouse Reg1 harbors two putative HREs in its promoter region
in the vicinity of the translation start site (TSS) (HRE1 and HRE2;
Figure 7B; Supplemental Experimental Procedures). Therefore,
we next asked whether Reg1 expression is inducible via the
activity of HIF1a and/or HIF2a. To test this idea, we made a
luciferase reporter vector containing the mouse Reg1 promoter
region (500-TSS), where two putative HREs are located (Fig-
ure 7C), and conducted a luciferase assay. The overexpression
of constitutively active HIF2a, but not HIF1a, increased lucif-
erase activity (Figure 7D), suggesting that the Reg1 promoter
region is specifically responsive to HIF2a. Furthermore, the re-
porter harboring HRE1 responded to constitutive-active HIF2a,
but not the one lacking HRE1, suggesting that HRE1, but not
HRE2, in the murine Reg1 promoter region is the functional
HRE (Figures 7C and 7D). Collectively, these findings support a
model where Reg1 is inducible upon iron deficiency via the
HIF2a-responsive HRE.
To test whether the physiological changes in Reg1 expression
during iron deficiency impact iron homeostasis, we next utilized
the Reg1 hypomorphic strain of mouse, which was fortuitously
obtained by the addition of FLAG at the 50 end of the Reg1 coding
sequence (Figures S7A and S7B). In the duodenal epithelial cells
of these hypomorphic mice, Reg1 expression levels decreased
to 30%of those of control mice (Figure S7C).While hypomorphic
mice did not show any signs of inflammation, unlike Reg1/
mice (data not shown), they suffered from microcytic anemia
and iron deficiency at the age of 3–4 weeks (Figures S7D and
S7E). These findings suggest that the physiological changes in
Reg1 expression, observed under iron-deficient conditions, con-
trol iron homeostasis.
To further analyze the physiological role of the regulation of
Reg1 expression in iron metabolism, we utilized the model of
chronic iron deficiency induced by a low-iron diet, in which
Reg1 expression is induced (Figure 7A). In this model, anemia
was more severe in Reg1fl/flVillin-Cre+ mice than in control
mice at all time points with the low-iron diet (Figure 7E). Also,
anemia progressed more rapidly in Reg1fl/flVillin-Cre+ mice (Fig-
ure 7F). These findings support a model where induction of Reg1
in duodenal epithelial cells facilitates iron uptake during iron
deficiency.
DISCUSSION
In the current study, we revealed that Reg1 serves as a critical
regulator in iron homeostasis. This conclusion is based on the
following findings: (1) Reg1 destabilized a set of mRNAs relating
to iron homeostasis, including TfR1 and PHD3; (2) Reg1/mice
suffered from severe iron deficiency anemia, which was largely
independent of inflammation and hepcidin; (3) inhibition of
PHD3 activity ameliorated the defect in duodenal iron uptake
found in Reg1/ mice; and (4) Reg1 expression was inducible
upon iron deficiency via HIF2a. These findings established a
working model for Reg1-mediated regulation of duodenal iron
absorption (Figure S7F). Upon iron deficiency, accumulated
HIF2a transactivates Reg1 via the HRE in the Reg1 promoter.
Reg1 protein then promotes mRNA decay of PHD3, leading to
further stabilization of HIF2a. Thus, Reg1 forms a positive feed-
back mechanism for HIF2a activation in the duodenum.
Although it was proposed that TfR1 mRNA undergoes endo-
nucleolytic degradation via its 30 UTR, endogenous endonucle-
ases for TfR1 mRNA decay have long remained unidentified
(Binder et al., 1994). In this study, we identified Reg1 as a
nuclease responsible for endonucleolytic cleavage of TfR1
mRNA. We found that the 30 UTR of TfR1 mRNA contains a
Reg1-responsive sequence that is predicted to form a stem-
loop structure. Distinct from that of IREs, the loop pattern in
the stem-loop structure found in TfR1 mRNA is pyrimidine-pu-
rine-pyrimidine, consistent with our findings from a genome-
wide analysis of Reg1 targets (Mino et al., 2015). This view is
also supported by a previous study, which demonstrated the
(D) mRNA expression levels (RPKM) of PHD genes in the duodenum and liver of wild-type and Reg1–/– mice (n = 2).
(E) Immunoblot analysis of PHD3 and b-actin in the duodenal epithelial cells from Reg1/ mice (n = 4). NS, non-specific band.
(F) HEK293T cells were co-transfected with pGL3-mPHD3-30 UTR and the expression plasmids for Reg1-WT, Reg1-D141N, or mock. After 48 hr of incubation,
the luciferase activity of cell lysates was determined.
(G) HEK293 Tet-Off cells were co-transfected with pTREtight-mPHD3-CDS-30 UTR, together with the Reg1 expression vector or the control (mock). Total RNAs
were extracted after Dox (1 mg/mL) treatment, and levels of PHD3 mRNA were measured by qRT-PCR.
(H) HEK293T cells were transfected with Reg1-D141N expression vector or the control (empty). RNA-protein complexes were immunoprecipitated, and levels of
PHD3 mRNA and 18S rRNA were measured by qRT-PCR.
Data are expressed asmean ±SD of biological replicates (C and D) or triplicates (F–H). *p < 0.05, ***p < 0.001 (Student’s t test; C andG). Data are representative of
three (F and G) or two (H) independent experiments. See also Figure S6 and Table S2.





Figure 6. Reg1 Regulates Duodenal Iron Uptake by Controlling PHD3 Expression
(A and B) Control and Reg1/ mice were fed a regular diet. Iron-deficient mice (ID; age-matched wild-type mice) were fed a low-iron diet for 4 weeks. (A) HGB
levels of control, Reg1/ and ID mice. (B) mRNA expression levels of HIF2a target genes in control, Reg1/ and ID duodenum (n = 4–5).
(C) Immunoblot analysis of ferroportin (Fpn1) and b-actin in the duodenal epithelial cells from Reg1/ mice (n = 2).
(D) Ferric reductase assay in control and Reg1/ duodenum. Increased activity of ferric reductase was detected as purple staining. The image is representative
of two independent experiments.
(E) Tissue iron levels of Reg1/ mice treated with DMOG or saline for 2 weeks (n = 3–4).
(legend continued on next page)
Cell Reports 19, 1614–1630, May 23, 2017 1625
region adjacent to this putative stem-loop structure (the region
between 76 and 90 in the TRS-1 30 UTR, which is a fragment of
human TfR1 mRNA utilized to determine the endonucleolytic
cleavage site) is the cleavage site by unknown endonucleases
(the region between 185 and 186 in the TRS-1 30 UTR) (Binder
et al., 1994) (Figure S1C). Although the biological role of TfR1
mRNA decay needs further clarification, it is clear that Reg1
serves as an endogenous endonuclease for the mRNAs of
iron-controlling genes, including TfR1 mRNA.
Multiple RNA-binding proteins are engaged inmRNA stabiliza-
tion or decay (Kafasla et al., 2014). For example, we have shown
that the RNA-binding proteins Reg1 and Roquin-1/2 target a
common set of mRNAs to ensure the cessation of gene expres-
sion, although the temporal and spatial regulation of mRNA
decay is distinct (Mino et al., 2015). TfR1 mRNA harbors five
IREs in its 30 UTR, which increases mRNA stability via IRPs. On
the other hand, we identified an evolutionarily conserved stem-
loop structure in TfR1 mRNA, which is recognized by Reg1.
We further showed that Reg1 has the potential to cancel TfR1
mRNA stabilization by IRPs, suggesting the model of steric
competition between IRPs and Reg1 binding. These findings
imply that Reg1 participates in elaborate regulatory mechanisms
that control the stability of TfR1 mRNA.
It has been reported that another RNA-binding protein, TTP,
which promotes the deadenylation of ARE-containing mRNAs,
negatively regulates TfR1mRNA (Bayeva et al., 2012). However,
it has also been suggested that endonucleolytic cleavage,
but not deadenylation, was involved in the decay of 30 UTR of
TfR1 mRNA under specific experimental conditions (Binder
et al., 1994). Here, we have shown that Reg1 destabilizes TfR1
mRNA through the recognition of an evolutionarily conserved
stem-loop structure, providing a likely identity of the previously
‘‘unknown endonuclease’’ for TfR1mRNA. It would be intriguing
in the future to clarify the relationship between endo- and exo-
nucleolytic degradation in controlling TfR1 mRNA.
It is widely viewed that hepcidin is a key regulator in anemia of
inflammation (Ganz and Nemeth, 2015; Weiss and Goodnough,
2005). We have previously shown that Reg1 suppresses the
expression of IL-6, which is a strong inducer of hepcidin (Mat-
sushita et al., 2009). Nevertheless, we have found that hepcidin
levels are highly suppressed in Reg1/ mice despite severe
autoimmune inflammation. Hepcidin mRNA levels in the liver,
which is the main source of serum hepcidin, were virtually unde-
tectable in Reg1/ mice. These findings clearly indicate that
anemia in Reg1/mice is not caused by hepcidin upregulation.
It is plausible that hepcidin suppression is caused by severe iron
deficiency in the liver, since iron supplementation, at least to
some extent, upregulated hepcidin mRNA expression. Also, er-
ythroferrone upregulation produced by erythroblasts contributes
to the suppression of hepcidin in Reg1/mice. Taken together,
the anemia and iron deficiency observed inReg1/mice are not
typical of the anemia of inflammation, which is largely dependent
on hepcidin-mediated suppression of Fpn1. Furthermore, we
have found that Reg1 plays an essential role in iron uptake
through the destabilization of PHD3 mRNA and that its expres-
sion is inducible upon iron deficiency via HIF2a. Thus, while sup-
pression of the systemic iron hormone hepcidin promotes
duodenal iron export via stabilization of Fpn1, Reg1 may serve
as a local facilitator of iron uptake in the duodenum via the
PHD3-HIF2a axis under conditions of iron deficiency.
The role of Reg1 in controlling iron homeostasis is largely
distinct from its role in the regulation of inflammation. First, we
demonstrated that mice deficient in both Reg1 and Rag2, in
which mature lymphocytes and immunoglobulins are absent,
totally recapitulated the features of anemia found in Reg1/
mice. Second, we failed to find gastritis in Reg1/mice despite
extensive histological examination, as reported previously (Zhou
et al., 2013). Third, mice lacking Reg1 in intestinal epithelial cells
alone had iron deficiency anemia without any obvious evidence
of inflammation. Whereas a previous report suggested that
Reg1/ mice develop anemia because of autoimmunity to
RBCs and parietal cells (Zhou et al., 2013), the findings above,
particularly the fact that antibodies are not necessary in the
development of anemia under Reg1 deficiency, failed to support
this observation. Although the contribution of autoimmune dis-
ease to altered iron homeostasis in Reg1/ mice needs further
clarification, this study clearly demonstrates that mechanisms
independent of autoimmune disease are sufficient to induce
iron deficiency anemia in Reg1/ mice.
Mice that lack Reg1 only in intestinal epithelial cells developed
iron deficiency anemia, although the phenotype was milder
compared to Reg1/ mice. This difference may result from
the incomplete deletion of Reg1 in the target organ due to the
limitations of the Cre-loxP system. Since duodenal epithelial
cells have the capacity to adaptively increase iron uptake by
20-fold during periods of iron deficiency (Carpenter and Um-
madi, 1995), the remaining activity of Reg1 in a small portion of
cells may compensate for the decline in iron uptake. Indeed, a
percentage of duodenal epithelial cells in Reg1fl/flVillin-Cre+
mice harbor intact Reg1 (Figure 4C). This view is supported by
the observation that a low-iron diet exacerbates the phenotype
of mice lacking Reg1 in intestinal epithelial cells. It is of note
that these phenotypes of Reg1fl/flVillin-Cre+ mice mentioned
above were reminiscent of those of the mice that lack HIF2a in
intestinal epithelial cells (Taylor et al., 2011). Taylor et al. (2011)
reported that HIF2afl/flVillin-Cre+ mice show severe anemia
only after treatment with a low-iron diet. This similarity in pheno-
type implies a mechanistic overlap of Reg1 and HIF2a.
Iron homeostasis is tightly controlled during inflammatory
responses. We have previously shown that the expression of
Reg1 is controlled by a variety of inflammatory stimuli. Reg1
was shown to be a lipopolysaccharide (LPS)-inducible gene in
PECs (Matsushita et al., 2009). In response to signaling through
the IL-1 receptor or Toll-like receptors, Reg1 is ubiquitinated and
(F) Hematological parameters of control, PHD3/, Reg1/ and PHD3/Reg1/ mice (n = 9–15).
(G) Iron levels of each organ from 5-6-week-old control, PHD3/, Reg1/ and PHD3/Reg1/ mice (n = 10–19).
Each symbol represents the value from individual mice and horizontal lines indicate the mean (E–G). Data were pooled from 2 (E), 11 (F), or 12 (G) independent
experiments. Data are expressed as mean ± SD of biological replicates (A and B). *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test (E–G) or one-way ANOVA
with Bonferroni correction (A and B). See also Figure S5.






Figure 7. HIF2a Transcriptionally Upregulates Reg1 to Activate a Positive Feedback Loop
(A) Reg1 mRNA expression levels in control and ID duodenums (n = 4–5).
(B) Schematic representation of two putative HRE sites in the murine Reg1 promoter region.
(C and D) HCT116 cells were co-transfected with a series of luciferase reporter plasmids (C), together with the expression plasmids for constitutive-active mutant
HIF1a or HIF2a, or empty plasmid as a control (mock). After 24 hr of incubation, luciferase activity of cell lysates was determined (D). Data are representative of
three independent experiments.
(legend continued on next page)
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then degraded (Iwasaki et al., 2011). Also, T cell receptor
stimulation leads to the cleavage of Reg1 by Malt1/paracaspase
(Uehata et al., 2013). In addition, we showed that the transcrip-
tion of Reg1 is also responsive to HIF2a. These elaborate
transcriptional and post-transcriptional regulations of Reg1
expression may facilitate crosstalk between inflammation and
iron homeostasis.
We identified PHD3mRNA as a target of Reg1 for degradation.
Previous studies revealed that PHD family members function
redundantly or non-redundantly depending on experimental set-
tings and tissues. It has been reported that PHD family members
play an overlapping role in protecting from radiation-induced
gastrointestinal toxicity in the large and small intestine (Taniguchi
et al., 2014). However, in the intestine, the duodenum is the main
site of dietary iron uptake, and the role of each PHD family mem-
ber in the regulation of HIF2amight not be the same. Indeed, we
found that PHD3 mRNA was the dominant transcripts among
PHD family members in the duodenum lacking Reg1, supporting
the notion that PHD3 is an important regulator of iron homeosta-
sis in the duodenum. Also, we have shown that Reg1-mediated
decay of PHD3mRNA is critical for promoting iron uptake in the
duodenum.Moreover, several other studies have suggested that
PHD3 has a specific role in destabilizing HIF2a and is subjected
to differential regulation (Appelhoff et al., 2004; Taniguchi et al.,
2013; Walmsley et al., 2011). Collectively, these findings support
the notion that PHD3 in the duodenum has a non-redundant role
and is subjected to differential regulation.
We have shown that Reg1-mediated decay of PHD3 mRNA
participates in a positive feedback loop that amplifies the activity
of HIF2a. When this loop was disrupted by lack of Reg1 in intes-
tinal epithelial cells, the anemia induced by a low-iron diet was
exacerbated more rapidly in vivo. These findings suggest that
Reg1-mediated positive feedback expression of HIF2a is critical
for efficient duodenal iron uptake under conditions of iron defi-
ciency. Interestingly, another hypoxia-inducible factor, HIF1a,
is known to be amplified via PHD3 and PKM2 (Luo et al., 2011;
Palsson-McDermott et al., 2015). Also it has been reported
that, upon hypoxia, a HIF-inducible microRNA activates HIF1a
by decreasing levels of glycerol-3-phosphate dehydrogenase
1-like (GPD1L) (Kelly et al., 2011). Thus, positive feedback could
be a common regulatory mechanism for HIF activation.
Lack of PHD3 in Reg1-deficient mice significantly improved
iron deficiency anemia observed in Reg1 single-knockout mice.
However, the effect of PHD3 ablation in fully restoring iron levels
is not perfect, suggesting that Reg1 has additional target mRNAs
for controlling iron uptake. Indeed, a search of genes upregulated
in Reg1/ duodenum identified HIF3a as a potential target of
Regnase-1, though the difference in expression between wild-
type and Reg1/ duodenum was markedly less significant
compared to PHD3 (p = 5.08 3 103 versus p = 6.15 3 108)
(Table S2). HIF3a has been implicated in the inhibition of HIF1/
2a and potentially contributes to impairedHIF2a activation under
Reg1deficiency, though its functionmight bedifferent depending
on splice variants, and its role in iron metabolism is not known.
Although it is plausible that Reg1 controls duodenal iron uptake
via HIF3a and other modestly regulated target genes in addition
to PHD3, further studies are needed to fully uncover the mecha-
nisms of iron uptake regulation.
In conclusion, we have clearly shown that Reg1 is critical for
mRNA destabilization of iron-controlling genes and facilitation
of duodenal iron uptake by acting as the amplifier of HIF2a acti-
vation. Our results will provide insight into the regulation of iron-
regulating transcripts via RNA-binding proteins.
EXPERIMENTAL PROCEDURES
Mice
Regnase-1/ (Reg1/), Reg1fl/fl, Rag2/, PHD3/, and Villin-Cre trans-
genic mice have been described previously (el Marjou et al., 2004; Matsushita
et al., 2009; Shinkai et al., 1992; Takeda et al., 2006; Uehata et al., 2013). Hypo-
morphic FLAG-Reg1 mice were generated as described in Supplemental
Experimental Procedures. Male and female animals were used between 3
and 9 weeks of age. All animal experiments were conducted in compliance
with the regulations approved by the Committee for Animal Experiments of
the Institute for Frontier Life and Medical Sciences, Kyoto University. Please
see Supplemental Experimental Procedures for details regarding animal
experiments.
Tissue Harvest
Please see Supplemental Experimental Procedures for details.
Flow Cytometric Analysis
Flow cytometric analysis was performed as described previously (Matsushita
et al., 2009) and in Supplemental Experimental Procedures.
Isolation of Duodenal Epithelial Cells
Duodenal epithelial cells were isolated as described previously (Nowarski
et al., 2015) and in Supplemental Experimental Procedures.
Immunoblot Analysis
Please see Supplemental Experimental Procedures for a list of antibodies used
in this study and detailed procedures. Chemiluminescent detection was per-
formed using ImageQuant LAS 4000 or Amersham Imager 600 (GE Health-
care). Densitometric analysis was performed using NIH ImageJ software.
qPCR Analysis
Please see Supplemental Experimental Procedures for detailed procedures
and primers used in this study.
RNA Sequencing and Bioinformatics Analysis
Proximal duodenums were immersed in TRIzol (Invitrogen) and immediately
homogenized. Total RNA was then extracted according to the manufacturer’s
instructions. Transcriptome data were collected as described previously (Ue-
hata et al., 2013). Themethod DESeqwas utilized to estimate significant differ-
entially expressed genes between wild-type and Reg1-deficient duodenums
(duplicate samples).
HREs were predicted in the Reg1 promoter by scanning them with the cor-
responding position weight matrix (PWM) from the Jaspar database (matrix ID:
MA0259.1). A PWM threshold score was set in a way that results in approxi-
mately one predicted binding site per 5 kb of the mouse genome (mm10).
Scanning of the region500 to1 relative to the Reg1 TSS resulted in two sig-
nificant hits for the HRE.
(E and F) Reg1fl/flVillin-Cre+ and control mice were fed a low-iron diet for 4 weeks (n = 8). Hematological parameters were determined at the indicated time points
(E). The relative change in hematological parameters before (week 0) and after (week 4) the induction of iron deficiency (F) is shown.
Each symbol represents the value from individual mice, and horizontal lines indicate the mean (F). Data are expressed as mean ± SD of biological replicates
(A and E) or of triplicates (D). *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test) compared to control (A, E, and F). See also Figure S7.
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Analysis of Microarray Datasets
Microarray datasets (GEO: GSE14891) have been described previously (Mat-
sushita et al., 2009). These datasets were analyzed as described in Supple-
mental Experimental Procedures.
Hematological Analysis
Hematological analysis was performed using Celltac a hematology analyzers
(MEK 6450, Nihon Kohden).
Tissue and Serum Iron Quantification
Tissue and serum iron quantification was conducted using a metalloassay kit
(ferrozine method) according to the manufacturer’s instructions (MG Metallo-
genics) as described in Supplemental Experimental Procedures.
Determination of UIBC
UIBC was determined using a microassay UIBC kit (MG Metallogenics) ac-
cording to the manufacturer’s instructions as described in Supplemental
Experimental Procedures.
Ferric Reductase Assay
Ferric reductase assay was performed as described previously (Shah et al.,
2009) and in Supplemental Experimental Procedures.
Histological Analysis
Tissue-iron detection was performed in formalin-fixed paraffin-embedded
sections stained with Berlin blue.
RNA Secondary Structure Prediction
The mfold program was used for RNA secondary structure predictions (Zuker,
2003).
Luciferase Assay
Luciferase assay was performed as described previously (Matsushita et al.,
2009) and in the Supplemental Experimental Procedures.
mRNA Decay Assay
The mRNA decay assay was performed as described previously (Matsushita
et al., 2009) and in Supplemental Experimental Procedures.
RIP Assay
Please see Supplemental Experimental Procedures for details.
Immunoprecipitation of FLAG-Reg1
Please see Supplemental Experimental Procedures for details.
Statistical Analysis
Results are expressed as mean ± SD. Statistical analyses were performed us-
ing Prism v.5 (GraphPad). Statistical significance was calculated using a two-
tailed Student’s t test or one-way ANOVA with Bonferroni correction. p values
of less than 0.05 were considered significant (*p < 0.05, **p < 0.01, ***p < 0.001,
#p < 0.05, ##p < 0.01, ###p < 0.001).
ACCESSION NUMBERS
The accession number for the RNA-sequencing data in Table S2 is DDBJ:
DRA003215.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2017.05.009.
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Figure S1. TfR1 expression is elevated in Reg1–/– cells even after iron supplementation,
Related to Figure 1.
(A) Total splenocytes were harvested from control and Reg1–/– mice and then cultured in iron-
supplemented medium (100μM hemin) for 8 hours. Cells were then harvested, stained and analyzed
using flow cytometry. Mac1+ or Ter119+ populations were gated and the mean fluorescence
intensity (MFI) of TfR1 in each gated population was calculated (n=6). Data were pooled from 2
independent experiments.
(B) Control and Reg1–/– mice were injected intraperitoneally with saccharated ferric oxide
(50mg/kg) 3 times a week for 3 weeks. Then total splenocytes were harvested, stained and analyzed
using flow cytometry. CD11blo F4/80+ red pulp macrophages (RPM) and Ter119+ erythroblasts
were gated and the MFI of TfR1 in each gated population was calculated (n=3-4). Data were pooled
from 2 independent experiments.
(C) Secondary structure model of TRS-1 mRNA (partial) (Horowitz and Harford, 1992). TRS-1 is
the truncated TfR1 mRNA used to identify the endonucleolytic cleavage site in the previous study
(Binder et al., 1994). The stem-loop structure targeted by Reg1 (Figure 2G) was shown in red. The
endonucleolytic cleavage site was derived from Binder et al.
Data are expressed as mean ± SD. *p < 0.05, **p < 0.01 in one-way-ANOVA with Bonferroni
correction (A and B).











































































































































































Figure S2. IRP2 is post-translationally upregulated in Reg1–/– tissues, Related to Figure 3.
(A) mRNA expression levels in the liver of control and Reg1–/– mice (n=4-5). Data were pooled
from two independent experiments.
(B-C) Immunoblot analysis of IRP2 and β-actin in indicated tissues from control and Reg1–/– mice.
Data are representative of two independent experiments.
(D-E) Immunoblot analysis of ferritin and β-actin in indicated tissues from control and Reg1–/–
mice. Data are representative of two independent experiments.
(F) mRNA expression levels of Irp1 and Irp2 in the liver and duodenum of control and Reg1–/–
mice (n=3).





















































































































































































Figure S3. Reg1–/– mice develop severe anemia and iron deficiency mainly independent of
inflammation, Related to Figure 3.
(A) Hematological parameters of control, Rag2–/–, Reg1–/– and Rag2–/–Reg1–/– mice (n=4). WBC,
white blood cells; RBC, red blood cells; HGB, hemoglobin; HCT, hematocrit; MCV, mean
corpuscular volume; MCHC, mean corpuscular hemoglobin concentration; ns, not significant. Data
were pooled from 4 independent experiments.
(B) Iron levels of each organ from control, Rag2–/–, Reg1–/– and Rag2–/–Reg1–/– mice (n=3-5). Data
were pooled from 3 independent experiments.
(C) Hematoxylin and eosin stain of the stomach, duodenum and liver and Berlin blue stain of the
duodenum from control, Rag2–/–, Reg1–/– and Rag2–/–Reg1–/– mice.
(D) Hepcidin mRNA expression levels in the liver of control, Rag2–/–, Reg1–/– and Rag2–/–Reg1–/–
mice (n=3).
Each symbol represents the value from individual mice and Horizontal lines indicate the mean (A
and B). Data are expressed as mean ± SD (D). *p < 0.05, **p < 0.01, ***p < 0.001 in one-way-





Figure S4. Reg1fl/flVillin-Cre+ mice show no sign of inflammation
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Figure S4. Reg1fl/flVillin-Cre+ mice show no sign of inflammation, Related to Figure 4.
(A) Macroscopic appearance of the colon from control and Reg1fl/flVillin-Cre+ mice.
(B) Hematoxylin and eosin stain of the duodenum and liver from control and Reg1fl/flVillin-Cre+
mice.
(C-D) mRNA expression levels in the liver (C) and duodenum (D) of control and Reg1fl/flVillin-Cre+
mice (n=5).
(E) Total splenocytes were harvested from control and Reg1fl/flVillin-Cre+ mice, stained and
analyzed using flow cytometry as indicated in the figure.
Data are expressed as mean ± SD (C and D). Representative images of each genotype are shown


































































Figure S5. Supplementation of iron or DMOG ameliorates iron deficiency in Reg1–/– mice
(Day) 0 21














































































































































Control Reg1–/– Control Reg1–/– Control Reg1–/–
Figure S5. Supplementation of iron or DMOG ameliorates iron deficiency in Reg1–/– mice,
Related to Figure 4.
(A) The experimental procedure of iron administration into mice. Control and Reg1–/– mice were
injected intraperitoneally with saccharated ferric oxide (50 mg/kg) 3 times a week for 3 weeks.
(B) Tissue and serum iron levels of control and Reg1–/– mice treated with saline or iron (n=2-5).
(C) Hepatic hepcidin mRNA expression levels in control and Reg1–/– mice after the iron treatment
(n=3-5). Data were pooled from two independent experiments.
(D) mRNA levels of HIF2α target genes in the duodenum of control and Reg1–/– mice treated with
DMOG or saline for 6 h (n=3-4). Data were pooled from two independent experiments.
(E) Tissue iron levels of age-matched wild-type mice treated with DMOG or saline for 2 weeks
(n=4).
Each symbol represents the value from individual mice. Horizontal lines indicate the mean (B and
E). Data are expressed as mean± SD (C and D). *p < 0.05, **p < 0.01, ***p < 0.001 in Student’s t
test (D and E) or in one-way-ANOVA with Bonferroni correction (B and C). ns, not significant.
Figure S6. Identification and validation of Reg1 target genes in the duodenum






























































































































































































Figure S6. Identification and validation of Reg1 target genes in the duodenum, Related to
Figure 5.
(A-C) Total RNA was harvested from Reg1–/– and control duodenums (n=2), and subjected to
transcriptome analysis. Immune-related genes and non-immune genes were selected based on the
GO analysis (see Extended Experimental Procedures). Scatter plot comparing the expression of
immune-related genes (2,081 genes, A) and non-immune genes (12,620 genes, B) in the duodenum
from wild-type and Reg1–/– mice, and classification of significantly up-regulated genes in Reg1–/–
duodenum based on the GO analysis (C) were shown.
(D) Hif3a mRNA levels in the duodenum of control and Reg1–/– mice (n=4).
(E-G) HEK293T cells were co-transfected with a series of luciferase reporter plasmids and the
expression plasmids for wild-type Reg1 (Reg1-WT), mutant Reg1 (Reg1-D141N), or empty
plasmid as a control (Mock). After 48 h of incubation, the luciferase activity of cell lysates was
determined (E and G). The predicted stem-loop structure of mouse PHD3 3′ UTR (912-935). The
canonical pyrimidine-purine-pyrimidine loop is indicated as red (F).
Data are expressed as mean± SD of biological replicates (D) or triplicates (E and G). *p < 0.05 in
Student’s t test (D).



































































5′- … ATGGACTACAAAGACGATGACGACAAGAGTGA… -3′
5′ UTR CDS
Reg1 locusATG
5′- … TGTGAAATATGAGTGACCCTTGTGGAACGA… -3′




















































































































































































Figure S7. The role of the regulation of Reg1 expression in iron homeostasis, Related to Figure
7.
(A) Scheme of the generation of FLAG-Reg1 knock-in mice. Gene-editing strategy mediated by
CRISPR/Cas9 system was used to insert the FLAG sequence into 5′ end of Reg1 coding sequence.
The resulting mice were used as a Reg1 hypomorphic strain.
(B) Immunoblot analysis of FLAG-Reg1 and β-actin in the duodenal epithelial cells from control
and FLAG-Reg1 mice (n=2). Duodenal epithelial cells were subjected to immunoprecipitation with
anti-FLAG antibody, followed by immunoblotting.
(C) Immunoblot analysis of Reg1 and β-actin in the duodenal epithelial cells from control and
FLAG-Reg1 mice (n=2). NS, non-specific band.
(D) Hematological parameters of control and hypomorphic FLAG-Reg1 mice at the age of 3-4
weeks (n=4). WBC, white blood cells; RBC, red blood cells; HGB, hemoglobin; HCT, hematocrit;
MCV, mean corpuscular volume; MCHC, mean corpuscular hemoglobin concentration; ns, not
significant.
(E) Tissue and serum iron levels of control and hypomorphic FLAG-Reg1 mice at the age of 3-4
weeks (n=6). Data were pooled from 3 independent experiments.
(F) Model of Reg1-mediated regulation of iron uptake in the duodenum.
Each symbol represents the value from individual mice. Horizontal lines indicate the mean (D and
E). *p < 0.05, **p < 0.01, ***p < 0.001 in Student’s t test (D and E). ns, not significant.
Supplemental Experimental Procedures 
 
Mice and Treatment 
Regnase-1–/– (Reg1–/–), Reg1fl/fl, Rag2–/–, PHD3–/– and Villin-Cre transgenic mice have been described 
previously (el Marjou et al., 2004; Matsushita et al., 2009; Shinkai et al., 1992; Takeda et al., 2006; Uehata 
et al., 2013). Rag2–/– or PHD3+/– mice were crossed with Reg1+/– mice to obtain Rag2+/–Reg1+/– or PHD3+/–
Reg1+/– mice, respectively. The resulting mice were intercrossed to generate the double knockout mice. 
Reg1fl/fl mice were crossed with Villin-Cre transgenic mice. Unless otherwise specified, wild-type, 
heterozygous or Cre-negative mice were used as controls. All animal experiments were conducted in 
compliance with the regulations approved by the Committee for Animal Experiments of the Institute for 
Virus Research or the Institute for Frontier Life and Medical Sciences, Kyoto University. 
To directly administer iron in vivo, mice were injected intraperitoneally with saccharated ferric 
oxide (50 mg/kg, Nichi-Iko) 3 times a week for 3 weeks. The non-toxic dose was estimated according to 
Mencacci et al. (Mencacci et al., 1997). 
To rescue the HIF activity in vivo, we followed the method administering HIF hydroxylase 
inhibitor, dimethyloxaloylglycine (DMOG), with a slight modification from that of Forristal et al. (Forristal 
et al., 2013). Reg1–/– and age-matched wild-type mice were intraperitoneally administered DMOG diluted 
in PBS (400mg/kg) 3 times a week for 2 weeks.  
To induce iron deficiency in mice, mice were fed with low-iron diet (3.4 ppm, Clea) for 4 weeks. 
This treatment was sufficient to induce iron-deficiency anemia as shown in Figure 6A. 
 
Generation of Hypomorphic FLAG-Reg1 Mice 
The FLAG-Reg1 knock-in mice were generated by using clustered regularly interspaced short palindromic 
repeats/CRISPR-associated proteins 9 (CRISPR/Cas9)-mediated genome-editing technology as previously 
described (Fujihara and Ikawa, 2014). Briefly, pX330 humanized Cas9/synthetic guide RNA (sgRNA) 
expressing plasmid (Addgene) was digested with BbsI, and ligated with annealed sgRNA oligos targeting 
the 5′ end of Reg1 coding sequence. The constructed pX330 plasmid was suspended in PBS together with 
the donor single strand oligo which contains FLAG coding sequence, and injected into fertilized eggs of 
C57BL/6J mice. Successful insertion was confirmed by direct sequencing. 
 
Reagents and Cells 
Antibodies for immunoblot analysis were as follows: HRP anti-β-actin (C-11; Santa Cruz Biotechnology), 
anti-PHD3 (NB100-303; Novus Biologicals), anti-ferroportin (MTP11-A; Alpha Diagnostic International) 
anti-ferritin (ab75973; Abcam), and anti-FLAG (F3165 and F7425; Sigma). The monoclonal anti-IRP2 
antibody was kindly provided by K. Iwai (Kyoto University). The polyclonal rabbit antibody for Reg1 has 
been described (Iwasaki et al., 2011). Secondary HRP-conjugated antibodies were from GE Healthcare. 
Antibodies for FACS analysis were from BD Biosciences, BD Pharmingen or BioLegend. Actinomycin D 
(ActD), doxycycline hyclate (Dox), hemin, deferoxamine mesylate (DFO) and Nitrotetrazolium Blue 
chloride were purchased from Sigma. DMOG was purchased from Calbiochem. G418 disulfate and 2-
mercaptoethanol were from Nacalai Tesque. RNasin was from Promega. Complete Mini Protease Inhibitor 
Cocktail was from Roche. Media for cell culture were from Nacalai Tesque unless otherwise specified. 
Isolation of peritoneal exudate cells (PECs) was described previously (Matsushita et al., 2009). 
PECs were cultured in RPMI-1640 medium supplemented with 10% FBS, 100 U/ml of penicillin, 100 
μg/ml of streptomycin and 50 μM 2-mercaptoethanol. Bone marrow cells were isolated from tibia and femur. 
HEK293T cells were cultured in Dulbecco's modified eagle medium (DMEM) supplemented with 10% 
FBS, 100 U/ml of penicillin, 100 μg/ml of streptomycin and 50 μM 2-mercaptoethanol. Tet-off HEK293 
cells were purchased from Clontech and cultured in α-MEM supplemented with 10% Tet-approved FBS 
(Clontech), 100 U/ml of penicillin, 100 μg/ml of streptomycin and 100 μg/mL of G418. HCT116 cells were 
cultured in McCoy’s 5A medium (Invitrogen) supplemented with 10% FBS, 100 U/ml of penicillin and 100 
μg/ml of streptomycin.  
To perform the experiment of ex vivo splenocyte treatment, harvested splenocytes were incubated 
overnight in the medium supplemented with 100 μM hemin. 
Cells were transfected through the use of Lipofectamine 2000, 3000 or LTX (Invitrogen) or PEI 
Max (Polysciences) according to the manufacturer’s instructions. 
 
Plasmids 
The plasmids expressing wild-type and mutant Reg1 have been described (Matsushita et al., 2009). 
pXSSRα-IRP1 and pXSSRα-IRP2 were kindly provided by K. Iwai (Kyoto University). pcDNA3-HIF1α-
P402A/P564A and pcDNA3.1-HIF2α-P531A expressing constitutively active HIF1α and HIF2α were 
provided by E. Nakamura (Kyoto University). p5HRE-Luc was a gift from H. Harada (Kyoto University) 
(Harada et al., 2005). Full-length 3′ UTR of mouse and human TfR1, and mouse PHD3, parts (768-1525, 
768-940, 768-960) of mouse TfR1 3′ UTR, and parts (1-430, 401-830, 801-1230, 1201-1643) of mouse 
PHD3 3′ UTR were inserted into pGL3-promoter vector. A part (944-958) of mouse TfR1 3′ UTR and a 
part (912-935) of mouse PHD3 3′ UTR were added to the end of β-globin 3′ UTR and inserted into pGL3-
promoter vector through the use of DNA Ligation Kit Ver. 2.1 (Takara). Mouse TfR1 and PHD3 CDS+3′ 
UTR were inserted into pTREtight vector (Clontech). Mouse Reg1 promoter regions (-500-TSS, -200-TSS) 
were inserted into pGL4.10 vector. The deletion of the putative hypoxia-response element (HRE2) was 
conducted through the use of QuikChange Site-Directed Mutagenesis Kit (Agilent). Cloning was performed 
using In-Fusion HD Cloning Kit (Clontech) unless otherwise specified. 
 
Flow Cytometric Analysis 
To obtain single-cell suspension of splenocytes, spleens from mice were homogenized, treated with Red 
Blood Cell Lysing Buffer (Sigma), and resuspended in MACS buffer (0.5% BSA (Sigma), 2 mM EDTA 
and 1× DPBS). Then cells were stained with fluorescent-labeled antibodies for 15 min, washed and 
resuspended in MACS buffer. Flow cytometric data were collected using FACSVerse (BD Biosciences). 
Collected data were analyzed with FlowJo (TreeStar).  
 
Tissue Harvest 
Liver, heart, spleen, stomach, kidney and colon were resected en bloc at necropsy. As for the duodenum, 
the gastrointestinal tract between pyloric sphincter and 1 cm distal part from the sphincter was collected. 
Organs were processed immediately for western blot analysis and tissue iron measurement, or stored at -
80 °C in RNAlater (Qiagen) for RNA isolation according to the manufacturer’s instructions.  
 
Isolation of Duodenal Epithelial Cells 
To isolate duodenal epithelial cells, we followed the method of Nowarski et al. (Nowarski et al., 2015). 
Proximal duodenums were harvested, cut longitudinally, and washed in DPBS. Duodenums were placed in 
Dissociation Buffer 1 (30mM EDTA, 1.5mM DTT in 1× DPBS) on ice for 20 min. Then duodenums were 
placed in Dissociation Buffer 2 (30mM EDTA in 1× DPBS) 37 °C for 10 min. To release epithelium, 
duodenums were vigorously shaked (2.5-3.5 g, 90 cycles for 30 sec). Then remnant intestinal tissues were 
removed. The detached epithelium was collected by centrifugation and homogenized in TRIzol (Invitrogen) 
or RIPA buffer (1% Nonidet P-40, 1% SDS, 1% sodium deoxycholate, 150 mM NaCl, 20 mM Tris-HCl 
(pH 8.0), 10 mM EDTA and Complete Mini Protease Inhibitor Cocktail). 
 
Immunoblot Analysis 
Whole-cell extracts of tissue samples were prepared in RIPA buffer. Samples were mixed with sample buffer, 
boiled at 95 °C for 5 min and cooled on ice. For the detection of ferroportin, samples were not boiled. 
Samples were loaded on either 5-20%, 7.5% or 15% polyacrylamide gel (ATTO), electrophoresed, and 
transferred to PVDF membranes (Bio-Rad). The membranes were immersed in 5% skim milk (BD Difco) 
in TBS-T. Signal Enhancer HIKARI for Western Blotting and ELISA (Nacalai Tesque), Can Get Signal 
Immunoreaction Enhancer Solution (Toyobo) or 5% skim milk in TBS-T was used to dilute primary and 
secondary antibodies. Blots were developed using Luminata Forte Western HRP Substrate (Millipore) 
according to the manufacturer’s instructions. Chemiluminescent detection was performed using 
ImageQuant LAS 4000 or Amersham Imager 600 (GE Healthcare). Densitometric analysis was performed 
through the use of NIH ImageJ software. 
 
Quantitative PCR Analysis 
TRIzol (Invitrogen) or ISOGEN (Nippongene) was used for the isolation of total RNA, and ReverTra Ace 
with gDNA Remover (Toyobo) was used for cDNA synthesis according to the manufacturer’s instructions. 
For quantitative PCR, the synthesized cDNAs were amplified using Thunderbird SYBR qPCR Mix 
(Toyobo), or Universal SYBR Select Master Mix or PowerUp SYBR Green Master Mix (Applied 
Biosystems) according to the manufacturer’s instructions. Fluorescence was detected using 7500 real-time 
PCR system (Applied Biosystems). To determine the relative expression, mRNA expression levels of genes 
were normalized to the expression level of glyceraldehyde 3-phosphate dehydrogenase (Gapdh) or β-actin 
(Actb). 
 
RNA Sequencing and Bioinformatics Analysis 
Proximal duodenums were immersed in TRIzol (Invitrogen) and immediately homogenized using VH-10 
(AS ONE). Then total RNA was extracted according to the manufacturer’s instructions. Transcriptome data 
were collected as described previously (Uehata et al., 2013). The method DESeq was utilized to estimate 
significant differentially expressed genes between wild-type and Reg1–/– duodenums (duplicate samples) 
(Anders and Huber, 2010). Immune-related genes were defined based on Gene Ontology (GO) annotation 
terms. Gene ontologies (basic and GOslim; date 11/01/2015) and mouse annotations (GOC validation date 
09/01/2015) were downloaded from the Gene Ontology Consortium website (Ashburner et al., 2000). 
Immune-related genes were defined as genes associated with one or more of the following GO terms: 
GO:0002376 (“immune system process”), GO:0002682 (“regulation of immune system process”), 
GO:0006954 (”inflammatory response”), GO:0050727 (“regulation of inflammatory response”), 
GO:0042742 (“defense response to bacterium”) and GO:0034097 (“response to cytokine”), or any of their 
respective child annotations. Top-ranked up-regulated genes with non-immune-related annotations were 
sorted by adjusted p value after excluding the immune-related genes and genes without definitions. 
HREs were predicted in the Reg1 promoter by scanning them with the corresponding position 
weight matrix (PWM) from the Jaspar database (matrix ID: MA0259.1) (Mathelier et al., 2014). A PWM 
threshold score was set in a way that results in about one predicted binding site per 5kb of the mouse 
genome (mm10). Scanning of the region -500 to -1 relative to the Reg1 TSS resulted in two significant hits 
for the HRE. 
 
Analysis of Microarray Datasets 
Microarray datasets (GSE14891) have been described (Matsushita et al., 2009). These datasets were used 
to calculate robust multichip average (RMA) expression values as previously described (Matsushita et al., 
2009). The reprocessed data shown in Table S1 were utilized to compare the difference in mRNA expression 
at 0 h (without any stimulation) between wild-type and Reg1–/– PECs.  
 
Hematological Analysis 
Blood was collected from retro-orbital plexus of anesthetized mice. Blood for hematological analysis was 
collected into EDTA-2Na-containing tube (Capiject, Terumo Medical). Hematological analyses were 
performed using Celltac α hematology analyzers (MEK 6450, Nihon Kohden).  
 
Tissue and Serum Iron Quantification 
Tissue and serum iron quantification was conducted using Metalloassay Kit (Ferrozine method) according 
to the manufacturer’s instructions (MG Metallogenics). Tissue homogenates were mixed with 1M HNO3 
until the pH reached 2, and spun down to obtain the supernatant. Samples were mixed with R-A Buffer and 
the baseline absorbance of 570 nm of samples was determined (ODA) using iMark Microplate Absorbance 
Reader (BioRad). Then R-R Chelate Color was added to the samples, and after 5 min of reaction, the 
absorbance of 570 nm was again determined (ODB). To measure iron concentration in samples, the increase 
in absorbance, ODB-ODA, was calculated and compared with the standard curve. 
 
Determination of Unbound Iron Binding Capacity and Total Iron Binding Capacity 
Unbound iron binding capacity (UIBC) was determined using Microassay UIBC Kit (MG Metallogenics) 
according to the manufacturer’s instructions. Absorbance of 546 nm and 600 nm of samples was determined 
using Nanodrop 2000c Spectrophotometers (Thermo Fisher Scientific). Total iron binding capacity (TIBC) 
was determined by adding UIBC to serum iron values.  
 
Ferric Reductase Assay 
Ferric reductase assay was performed as previously described (Shah et al., 2009). In brief, proximal 
duodenums were washed in ice-cold 150mM NaCl, and incubated in Incubation Buffer (125mM NaCl, 
3.5mM KCl, 16mM HEPES/NaOH, and 1mM Nitrotetrazolium blue chloride) at 37 °C. Then the reaction 
was halted by washing the duodenum in ice-cold 150mM NaCl twice.  
 
Histological Analysis 
Tissue samples were fixed with 10% formalin solution or 4% paraformaldehyde/PBS. Tissue-iron detection 
was performed in formalin fixed paraffin-embedded sections stained with Berlin blue. 
 
RNA Secondary Structure Prediction 
The mfold program was used for RNA secondary structure predictions (Zuker, 2003).  
 
Luciferase Assay 
To identify Reg1 targets in 3′ UTR, HEK293T cells were co-transfected with luciferase reporter plasmid 
(pGL3 vector) and the expression plasmids for wild-type or mutant Reg1, or empty plasmid as a control. 
After 48 h of incubation, cells were lysed.  
For promoter assay, HCT116 cells were co-transfected with luciferase reporter plasmids 
harboring mouse Reg1 promoter regions (pGL4.10 vector) and the expression plasmids for constitutively 
active HIF1α (P402A/P564A) or HIF2α (P531A), or empty plasmid as a control. After 24 h of incubation, 
cells were lysed. 
Luciferase activity was determined with the Dual-Luciferase Reporter Assay system (Promega) 
and GloMax-Multi Detection System (Promega). The gene encoding renilla luciferase was transfected 
simultaneously as an internal control. 
 
mRNA Decay Assay 
To analyze mRNA decay using the Tet-Off system (Clontech), Tet-Off HEK293 cells were transfected with 
the pTREtight vector harboring full-length of mouse TfR1 or PHD3 CDS+3′ UTR, together with the 
expression vectors of wild-type Reg1 or control (Mock). After overnight incubation, cells were treated with 
Dox (1 μg/ml) and total RNA was harvested at the indicated time points. 
To analyze mRNA decay using primary cells, PECs from control and Reg1–/– mice were treated overnight 
with DFO (100 μM). The cells were then treated with ActD (1 μg/ml) and hemin (100 μM). Total RNA was 
harvested at the indicated time points following the treatment. 
 
RNA Immunoprecipitation 
HEK293T cells were transfected with the expression vector for mutant Reg1 (D141N), or empty plasmid 
as a control. After 48h of incubation, medium was removed, followed by UV cross-linking using CL-1000 
(UVP). Cells were lysed in RIP Lysis buffer (20 mM Tris-HCl (pH 7.4), 100mM KCl, 1.5 mM MgCl2, 0.5% 
NP-40, 0.2 U/mL RNasin and Complete Mini Protease Inhibitor Cocktail). Lysates were aliquoted to obtain 
input samples. Then cell lysates were mixed with Dynabeads Protein G (Novex) preincubated with anti-
FLAG antibody and incubated at 4 °C for 2 h with gentle rotation. Then beads were immobilized, washed 
5 times in RIP Wash buffer (20 mM Tris-HCl (pH 7.4), 150 mM KCl, 2.5 mM MgCl2, 0.2 U/mL RNasin 
and Complete Mini Protease Inhibitor Cocktail), and mixed with TRIzol (Invitrogen).  
 
Immunoprecipitation of FLAG-Reg1 
Duodenal epithelial cells were lysed in RIP Lysis buffer (20 mM Tris-HCl (pH 7.4), 100mM KCl, 1.5 mM 
MgCl2, 0.5% NP-40 and Complete Mini Protease Inhibitor Cocktail). Lysates were aliquoted to obtain input 
samples. Then cell lysates were mixed with Dynabeads Protein G (Thermo Fisher Scientific) preincubated 
with anti-FLAG antibody and incubated at 4 °C for 8 h with gentle rotation. Then beads were immobilized, 
washed 5 times in RIP Lysis buffer, and mixed with sample buffer.  
 
Statistical Analysis 
Results were expressed as mean ± SD. Statistical analyses were performed using Prism v.5 (GraphPad). 
Statistical significance was calculated with either two-tailed Student’s t-test or one-way ANOVA with 
Bonferroni correction. P values of less than 0.05 were considered significant. *p < 0.05, **p < 0.01, ***p 
< 0.001, #p < 0.05, ##p < 0.01, ###p < 0.001 were indicated. 
 
RT-qPCR primers used in this study 
Species Gene 
symbol 
Forward primer Reverse primer 
Mus musculus Gapdh AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 
Mus musculus Actb GGCTGTATTCCCCTCCATCG CCAGTTGGTAACAATGCCATGT 
Mus musculus Reg1 CGAGAGGCAGGAGTGGAAAC CTTACGAAGGAAGTTGTCCAGGCTAG 
Mus musculus Il-6 GTAGCTATGGTACTCCAGAAGAC ACGATGATGCACTTGCAGAA 
Mus musculus Hamp CTACAGAGCTGCAGCCTTTG GCAACAGATACCACACTGGGAATTG 
Mus musculus Epo CTCACTTCACTGCTTCGGGT GGAGGAAGTTGGCGTAGACC 
Mus musculus Erfe TCTACAGGCAGGACACTACACT TCACAGGCCCAGGAGGATAG 
Mus musculus TfR1 GCTAGTGTCAGAAAACCCAAGAGG GTTTCAGCCAGTTTCACACACTCC 
Mus musculus Fpn1 GACAGCTGTCTATGGACTGGTGG GCAGAGGATGACGGACACATTC 
Mus musculus Dmt1 CCACTGGAGACTCTGAGGAG CTGGGTCTAGGTAGGCAATGCTC 
Mus musculus Dcytb GCAGCGGGCTCGAGTTTAACTG CAGCGTTTAACCCGGCATGG 
Mus musculus FtL GTGAACCGCCTGGTCAACTTG CTCGGCCAATTCGCGGAAGAAG 
Mus musculus FtH CCATCAACCGCCAGATCAACC CTCCTCATGAGATTGGTGGAGAAAG 
Mus musculus PHD1 AGGCTATGTCCGTCACGTTG TGGGCTTTGCCTTCTGGAAA 
Mus musculus PHD2 GTAGAAGGTCACGAGCCAGG ATTGCCTGGATAACACGCCA 
Mus musculus PHD3 ATGGTGATGGCCGCTGTATC CTGCGGTCTGACCAGAAGAA 
Mus musculus Hif3a CACTGCTCAGGACATATGAG TCCAAAGCGTGGATGTATTC 
Mus musculus Slc38a1 GAGCTAACGGAGCTGCAGAAC CTGTTTGTGAGACTCCTCCTACTCTC 
Mus musculus Irp1 AACACCAGCAATCCATCCGT GGTGACCACTCCACTTCCAG 
Mus musculus Irp2 TTTGCTGCTATGAGGGAGGC ACCTCCAGGATTTGGTGCAT 
Mus musculus Il12b TGGTTTGCCATCGTTTTGCTG ACAGGTGAGGTTCACTGTTTCT 
Mus musculus Ifng TGAGTATTGCCAAGTTTGAGGTCA CGGCAACAGCTGGTGGAC 
Mus musculus Il1b GCAACTGTTCCTGAACTCAACT ATCTTTTGGGGTCCGTCAACT 
Mus musculus Tnf CCCTCACACTCAGATCATCTTCT GCTACGACGTGGGCTACAG 
Homo sapiens GAPDH GTTGCCATCAATGACCCCTTCATTG
ACC 
CAGCATCGCCCCACTTGATTTTGG 
Homo sapiens ACTB CACCATTGGCAATGAGCGGTTCC CTTCTGCATCCTGTCGGCAATGC 
Homo sapiens 18S CGGACAGGATTGACAGATTG CAAATCGCTCCACCAACTAA 
Homo sapiens TfR1 CTGCCAGCCCACTGTTGTAT GCCCAGTTGCTGTCCTGATA 
Homo sapiens PHD3 CATCGACAGGCTGGTCCTCTA CCACGTGGCGAACATAACC 
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